Hello orris

Hey! How can I help you today?

I’m emergency medicine final year student appearing for exams can you help me

Absolutely! I'm here to help you prep for your Emergency Medicine finals.

Here's what I can do for you:

Explain concepts - pathophysiology, mechanisms, clinical presentations
Work through cases - clinical scenarios and decision-making
Review protocols - ACLS, trauma (ATLS), toxicology, sepsis, etc.
Quiz you - spot questions, MCQs, or SAQs on any topic
Clarify guidelines - latest management protocols
High-yield topics - help you focus on what matters most for exams

I have access to medical textbooks and literature to give you accurate, detailed answers.

What topic would you like to start with?

Okay if I feel difficulty i will ask you

Sounds good! I'll be here whenever you need me. Good luck with your studies! 💪

Can you explain all about stemi and latest stemi guidelines

Great topic - STEMI is a cornerstone of emergency medicine. Let me pull from both the medical library and latest guidelines for you.

Searching sources...

Reading File

Finding Sources

Searching PubMed

"ST-elevation myocardial infarction" AND "guidelines"

Searching the Web

ACC AHA 2025 STEMI guidelines update latest recommendations

Now let me pull the actual textbook content and the 2025 guideline details in parallel:

Reading File

Reading Web Page

https://www.jacc.org/doi/10.1016/j.jacc.2025.01.018

Reading Article

PMID: 40014670

Let me get more detailed content from the textbooks and fetch the ACS flowchart image:

Reading File

Loading Image

Excellent - I now have comprehensive information. Here is a complete, structured guide to STEMI for your emergency medicine finals:

STEMI - Complete Guide for EM Finals

1. Definition & Pathophysiology

STEMI (ST-Elevation Myocardial Infarction) is a full-thickness (transmural) myocardial infarction caused by complete and sustained occlusion of a coronary artery, almost always by plaque rupture with superimposed thrombus formation. The result is cessation of blood flow to a territory of myocardium, leading to ischemia → injury → infarction if not reversed.

Pathological sequence:

Atherosclerotic plaque vulnerability → rupture/erosion
Platelet aggregation → thrombus formation
Complete coronary occlusion
Myocardial ischemia starts within minutes
Irreversible necrosis begins at ~20 min (subendocardium first) and progresses toward epicardium ("wavefront" phenomenon)
After 6 hours: near-complete transmural necrosis of at-risk territory

2. Clinical Presentation

Feature	Classic	Atypical (watch for these!)
Chest pain	Crushing, pressure, radiation to arm/jaw	Absent (especially diabetics, elderly, women)
Associated	Diaphoresis, nausea, vomiting, dyspnea	Epigastric pain, fatigue, syncope
Duration	>20 minutes, not relieved by nitrates	Variable

High-risk groups for atypical presentations: diabetics, elderly, women, post-transplant patients.

3. ECG Diagnosis

STEMI criteria (must know for exams):

Lead Group	Elevation Threshold	Territory
2 contiguous limb leads	≥1 mm	Inferior (II, III, aVF) or lateral (I, aVL)
2 contiguous precordial leads (V1-V4)	≥2 mm men, ≥1.5 mm women	Anterior
V4R	≥0.5 mm	Right ventricle

ECG evolution:

Hyperacute T waves (earliest, minutes)
ST elevation (injury pattern)
Q wave formation (necrosis, hours)
T wave inversion
ST normalization, persistent Q waves

STEMI equivalents (critical for EM!):

De Winter pattern - upsloping ST depression + peaked T waves in V1-V6 (LAD occlusion - no classic STE)
Posterior MI - ST depression V1-V3 + tall R wave (do posterior leads V7-V9)
Wellens syndrome - biphasic or deeply inverted T waves in V2-V3 (critical LAD stenosis, pre-infarction)
LBBB (new or presumed new) - treat as STEMI
Sgarbossa criteria - diagnose MI in LBBB

Localization:

Territory	Leads	Artery
Anterior	V1-V4	LAD
Lateral	I, aVL, V5-V6	LCx
Inferior	II, III, aVF	RCA (80%), LCx (20%)
Posterior	V7-V9, STD V1-V3	RCA/LCx
Right ventricle	V4R	RCA

4. Diagnosis in ED

ECG within 10 minutes of arrival - this is a Class I recommendation.

12-lead ECG: acquire and interpret within 10 minutes
Serial ECGs if initial non-diagnostic
High-sensitivity troponin (hs-cTn): measure ASAP; repeat at 1-2 hours (rapid rule-in/out) or 3-6 hours (standard protocol)
CBC, BMP, coagulation, CXR
Echo at bedside if diagnosis uncertain or to assess wall motion

5. Reperfusion - The Core of STEMI Management

The goal is to restore blood flow as fast as possible. Every 30-minute delay in reperfusion increases mortality.

Primary PCI (pPCI) - Preferred Strategy

Time targets (2025 ACC/AHA guidelines):

Scenario	Target
PCI-capable hospital	First medical contact (FMC) to balloon ≤90 minutes
Transfer from non-PCI hospital	FMC to balloon ≤120 minutes
Fibrinolysis if PCI not achievable	FMC to needle ≤30 minutes

Note: The concept of "first medical contact to device time" replaces the old "door to balloon" or "door to needle" terminology.

Why PCI > Fibrinolysis: In a large meta-analysis of 23 RCTs, pPCI was superior to thrombolytics at reducing death, reinfarction, and stroke. - Fuster and Hurst's The Heart, 15th Edition

Fibrinolysis - When PCI is Not Available in Time

Indication: When pPCI cannot be performed within 120 minutes of STEMI diagnosis.

Preferred agents: Fibrin-specific agents (tenecteplase, alteplase, reteplase) - give within 10 minutes of STEMI diagnosis.

Absolute contraindications to fibrinolysis:

Prior intracranial hemorrhage (any time)
Ischemic stroke within 3 months
Structural cerebrovascular lesion / intracranial neoplasm
Active internal bleeding (not menses)
Suspected aortic dissection
Significant closed-head/facial trauma within 3 months

Post-fibrinolysis:

If successful (≥50% ST resolution at 60-90 min) → angiography within 3-24 hours ("pharmacoinvasive strategy")
If failed reperfusion → rescue PCI immediately

6. Pharmacotherapy

ACS Treatment Flowchart

ACS Treatment Algorithm - Tintinalli's Emergency Medicine

Antiplatelet Therapy (DAPT - mandatory)

Drug	Dose	Notes
Aspirin	162-325 mg loading, then 75-100 mg daily	Give immediately
Ticagrelor	180 mg load, then 90 mg BD	Preferred with pPCI (2025 guidelines)
Prasugrel	60 mg load, then 10 mg daily	Preferred with pPCI; avoid if prior stroke/TIA, age >75, weight <60 kg
Clopidogrel	600 mg load, then 75 mg daily	Use if ticagrelor/prasugrel unavailable; no loading dose if >75 yrs + fibrinolysis

2025 ACC/AHA Key Update on DAPT:

DAPT for ≥12 months post-ACS for low bleeding risk
Transition to ticagrelor monotherapy ≥1 month post-PCI is now Class I to reduce bleeding (new recommendation)
Shorter DAPT (1-3 months) reasonable in selected high-bleeding-risk patients, then P2Y12 monotherapy

Anticoagulation

Drug	Setting	Dose
UFH (unfractionated heparin)	Primary PCI	70-100 U/kg IV bolus (without GPI); 50-70 U/kg if with GPI
Bivalirudin	Primary PCI	Alternative to UFH
Enoxaparin	Medical/fibrinolysis	30 mg IV + 1 mg/kg SC Q12H
Fondaparinux	Medical management	2.5 mg SC daily (avoid as sole anticoagulant for PCI)

Other Drugs

Drug	Indication	Notes
Beta-blockers	All STEMI (oral, within 24h)	Reduce VT/VF, reinfarction; avoid in cardiogenic shock, acute HF, PR >240ms, 2nd/3rd degree block, active asthma
ACE inhibitor / ARB	All STEMI, especially EF <40%	Start within 24h; reduces MACE
High-intensity statin	All STEMI	Start immediately (Class I, 2025 guidelines)
Nitrates	Chest pain relief	Avoid if RV infarction, hypotension, recent PDE5 inhibitor use
Morphine	Refractory pain	Use cautiously - may delay P2Y12 absorption
Oxygen	O2 sat <90%	Avoid routine O2 if sat ≥90%; may cause harm

Lipid Lowering (2025 Update)

High-intensity statin: Class I for all ACS
Add ezetimibe if LDL not at goal on statin
For recurrent atherothrombotic events within 2 years on max statin: LDL target <40 mg/dL may be considered (new 2025 recommendation)

7. Multivessel Disease in STEMI (Major 2025 Update!)

This is a heavily tested topic with major new guidance:

Scenario	Recommendation	Class
Hemodynamically stable STEMI + MVD	Complete revascularization (infarct + noninfarct arteries) recommended - either at index PCI or within 45 days	Class I
Cardiogenic shock + MVD	Routine PCI of noninfarct artery at time of primary PCI should NOT be performed (higher risk of death/renal failure)	Class III (Harm)
Low-complexity MVD, hemodynamically stable	Multivessel PCI at time of primary PCI may be preferred over staged approach	Class 2b

8. Complications of STEMI

Early (first 24-72 hours)

Arrhythmias: VF (leading cause of early death), VT, AF, complete heart block (inferior MI)
Right ventricular infarction (inferior STEMI + RV infarct): hypotension, JVD, clear lungs - treat with fluids, avoid nitrates/diuretics
Cardiogenic shock: SBP <90, low CO, high wedge pressure - treat with pPCI, vasopressors, MCS (IABP/Impella)

Mechanical Complications (days 3-7)

Free wall rupture - sudden cardiac death, Beck's triad
Ventricular septal defect (VSD) - new harsh holosystolic murmur, step-up in O2 saturation RA→RV
Papillary muscle rupture / acute MR - acute pulmonary edema, soft murmur

Subacute

Dressler syndrome (post-MI pericarditis) - weeks after MI, fever + pericardial rub + pleurisy, treat with aspirin/NSAIDs
LV thrombus - anticoagulate if detected
LV aneurysm - persistent ST elevation, paradoxical wall motion

9. Special Situations

STEMI + RV Infarction:

Occurs in 30-50% of inferior STEMIs
Clinical triad: hypotension + JVD + clear lungs
Check right-sided leads (V4R is most sensitive)
Treatment: fluids (preload dependent), avoid nitrates/diuretics, early pPCI

STEMI + Cardiogenic Shock:

Early revascularization is the only intervention proven to reduce mortality
Intra-aortic balloon pump (IABP) - not shown to improve mortality in recent RCTs
Newer MCS (Impella, ECMO) under study

10. 2025 ACC/AHA ACS Guideline - Key Changes Summary

Published February 27, 2025 in both Circulation and JACC (PMID: 40014670), this is a landmark unified guideline replacing the 2013 STEMI, 2014 NSTEMI, 2015 PCI, and 2016 DAPT guidelines.

Top 6 practice-changing updates:

DAPT transition: Ticagrelor monotherapy ≥1 month post-PCI is now Class I to reduce bleeding
Complete revascularization in MVD-STEMI: Class I - do it at index PCI or within 45 days
Lipid targets: High-intensity statin for all ACS (Class I); LDL <40 mg/dL for recurrent events
Aspirin dosing: Low-dose aspirin (≤100 mg) preferred for long-term therapy
Cardiogenic shock + MVD: Staged PCI confirmed - NO routine noninfarct artery PCI at time of primary PCI
ECG and troponin timing: 10-minute ECG, rapid hs-troponin protocols (0h/1-2h)

Quick Memory Aids for Exams

MONA used to be the mnemonic - now modified:

Morphine - use cautiously (not routinely)
Oxygen - only if SpO2 <90%
Nitrates - avoid in RV infarct/hypotension
Aspirin - give immediately (Class I)

Time targets to memorize:

ECG: 10 min
PCI-capable hospital balloon: 90 min
Transfer + balloon: 120 min
Fibrinolysis needle: 30 min
Fibrinolytic bolus from STEMI diagnosis: 10 min

Killip Classification (prognosis):

Class	Signs	Mortality
I	No HF signs	~5%
II	S3, basal rales	~10%
III	Pulmonary edema	~20-40%
IV	Cardiogenic shock	~80%

Sources: Tintinalli's Emergency Medicine, 9th Ed. - Fuster and Hurst's The Heart, 15th Ed. - Braunwald's Heart Disease - 2025 ACC/AHA ACS Guideline (Circulation, Feb 2025)

Hope that covers everything you need for STEMI! Let me know if you want to go deeper on any section, work through a clinical case, or move on to another topic.

Can you give it in a pdf

Reading File

Running Command

ls /home/daytona/workspace/ 2>/dev/null || echo "workspace empty or not found"

Running Command

mkdir -p /home/daytona/workspace/stemi-guide && python3 -c "import reportlab; print('reportlab ok')" && python3 -c "import markdown; print('markdown ok')" || echo "checking libs"

I'll generate a well-formatted PDF using ReportLab directly:

Writing File

~/stemi-guide/generate_stemi_pdf.py

from reportlab.lib.pagesizes import A4
from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle
from reportlab.lib.units import cm
from reportlab.lib import colors
from reportlab.platypus import (
    SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle,
    HRFlowable, PageBreak
)
from reportlab.lib.enums import TA_LEFT, TA_CENTER, TA_JUSTIFY
from reportlab.platypus import KeepTogether

OUTPUT = "/home/daytona/workspace/stemi-guide/STEMI_EM_Study_Guide.pdf"

doc = SimpleDocTemplate(
    OUTPUT,
    pagesize=A4,
    rightMargin=2*cm, leftMargin=2*cm,
    topMargin=2.5*cm, bottomMargin=2.5*cm,
    title="STEMI – Complete EM Study Guide",
    author="Orris AI"
)

W = A4[0] - 4*cm  # usable width

# ── Colour palette ──────────────────────────────────────────────────────────
RED      = colors.HexColor("#C0392B")
DARKRED  = colors.HexColor("#922B21")
BLUE     = colors.HexColor("#1A5276")
LBLUE    = colors.HexColor("#D6EAF8")
ORANGE   = colors.HexColor("#E67E22")
GREEN    = colors.HexColor("#1E8449")
LGREEN   = colors.HexColor("#D5F5E3")
LGREY    = colors.HexColor("#F2F3F4")
MGREY    = colors.HexColor("#BDC3C7")
WHITE    = colors.white

# ── Styles ───────────────────────────────────────────────────────────────────
base = getSampleStyleSheet()

def S(name, parent="Normal", **kw):
    return ParagraphStyle(name, parent=base[parent], **kw)

Title  = S("Title2",  fontSize=26, textColor=WHITE, leading=32,
           alignment=TA_CENTER, fontName="Helvetica-Bold")
Sub    = S("Sub",     fontSize=12, textColor=WHITE, leading=16,
           alignment=TA_CENTER, fontName="Helvetica")
H1     = S("H1",      fontSize=14, textColor=WHITE, leading=18,
           fontName="Helvetica-Bold", spaceAfter=2)
H2     = S("H2",      fontSize=11, textColor=BLUE, leading=15,
           fontName="Helvetica-Bold", spaceBefore=8, spaceAfter=3)
H3     = S("H3",      fontSize=10, textColor=DARKRED, leading=13,
           fontName="Helvetica-Bold", spaceBefore=4, spaceAfter=2)
Body   = S("Body",    fontSize=9,  leading=13, spaceAfter=3,
           alignment=TA_JUSTIFY)
Bullet = S("Bullet",  fontSize=9,  leading=13, leftIndent=14,
           firstLineIndent=-10, spaceAfter=2)
Small  = S("Small",   fontSize=7.5, textColor=colors.HexColor("#555555"),
           leading=10, alignment=TA_CENTER)
Bold9  = S("Bold9",   fontSize=9,  fontName="Helvetica-Bold", leading=13)
Warn   = S("Warn",    fontSize=9,  textColor=RED, fontName="Helvetica-Bold",
           leading=13)
Note   = S("Note",    fontSize=8.5, textColor=BLUE, leading=12,
           leftIndent=8)

def bullet(txt):
    return Paragraph(f"• {txt}", Bullet)

def h1_block(text, bg=BLUE):
    tbl = Table([[Paragraph(text, H1)]], colWidths=[W])
    tbl.setStyle(TableStyle([
        ("BACKGROUND", (0,0), (-1,-1), bg),
        ("TOPPADDING",    (0,0), (-1,-1), 5),
        ("BOTTOMPADDING", (0,0), (-1,-1), 5),
        ("LEFTPADDING",   (0,0), (-1,-1), 8),
        ("RIGHTPADDING",  (0,0), (-1,-1), 8),
        ("ROUNDEDCORNERS", [4]),
    ]))
    return tbl

def section_table(rows, col_widths, header_bg=BLUE, alt=True):
    """Styled table with coloured header row."""
    style = [
        ("BACKGROUND",    (0,0), (-1,0),  header_bg),
        ("TEXTCOLOR",     (0,0), (-1,0),  WHITE),
        ("FONTNAME",      (0,0), (-1,0),  "Helvetica-Bold"),
        ("FONTSIZE",      (0,0), (-1,-1), 8.5),
        ("LEADING",       (0,0), (-1,-1), 11),
        ("TOPPADDING",    (0,0), (-1,-1), 4),
        ("BOTTOMPADDING", (0,0), (-1,-1), 4),
        ("LEFTPADDING",   (0,0), (-1,-1), 5),
        ("RIGHTPADDING",  (0,0), (-1,-1), 5),
        ("GRID",          (0,0), (-1,-1), 0.4, MGREY),
        ("VALIGN",        (0,0), (-1,-1), "MIDDLE"),
    ]
    if alt:
        for i in range(1, len(rows), 2):
            style.append(("BACKGROUND", (0,i), (-1,i), LGREY))
    tbl = Table(
        [[Paragraph(str(c), Bold9 if r==0 else Body) for c in row]
         for r, row in enumerate(rows)],
        colWidths=col_widths
    )
    tbl.setStyle(TableStyle(style))
    return tbl

def warning_box(text):
    tbl = Table([[Paragraph(f"⚠ {text}", Warn)]], colWidths=[W])
    tbl.setStyle(TableStyle([
        ("BACKGROUND",    (0,0), (-1,-1), colors.HexColor("#FDEDEC")),
        ("LEFTPADDING",   (0,0), (-1,-1), 8),
        ("RIGHTPADDING",  (0,0), (-1,-1), 8),
        ("TOPPADDING",    (0,0), (-1,-1), 5),
        ("BOTTOMPADDING", (0,0), (-1,-1), 5),
        ("BOX",           (0,0), (-1,-1), 1, RED),
    ]))
    return tbl

def info_box(text, bg=LBLUE, tc=BLUE):
    style = S("IB", fontSize=9, textColor=tc, leading=13, leftIndent=4)
    tbl = Table([[Paragraph(text, style)]], colWidths=[W])
    tbl.setStyle(TableStyle([
        ("BACKGROUND",    (0,0), (-1,-1), bg),
        ("LEFTPADDING",   (0,0), (-1,-1), 8),
        ("RIGHTPADDING",  (0,0), (-1,-1), 8),
        ("TOPPADDING",    (0,0), (-1,-1), 5),
        ("BOTTOMPADDING", (0,0), (-1,-1), 5),
        ("BOX",           (0,0), (-1,-1), 0.8, tc),
    ]))
    return tbl

# ════════════════════════════════════════════════════════════════════════════
# CONTENT
# ════════════════════════════════════════════════════════════════════════════
story = []

# ── COVER PAGE ───────────────────────────────────────────────────────────────
cover = Table(
    [[Paragraph("STEMI", Title)],
     [Paragraph("Complete Emergency Medicine Study Guide", Sub)],
     [Spacer(1, 0.3*cm)],
     [Paragraph("Based on 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guidelines", Sub)],
    ],
    colWidths=[W]
)
cover.setStyle(TableStyle([
    ("BACKGROUND",    (0,0), (-1,-1), RED),
    ("TOPPADDING",    (0,0), (-1,-1), 18),
    ("BOTTOMPADDING", (0,0), (-1,-1), 18),
    ("ROUNDEDCORNERS", [6]),
]))
story += [Spacer(1, 1*cm), cover, Spacer(1, 0.5*cm)]

meta = Table([[
    Paragraph("For: Emergency Medicine Final Year Students", Small),
    Paragraph("Date: July 2026", Small),
    Paragraph("Sources: Tintinalli · Braunwald · Fuster & Hurst · PubMed", Small),
]], colWidths=[W/3]*3)
story += [meta, Spacer(1, 0.8*cm), HRFlowable(width=W, color=MGREY), Spacer(1, 0.3*cm)]

# ── 1. DEFINITION & PATHOPHYSIOLOGY ─────────────────────────────────────────
story += [h1_block("1. Definition & Pathophysiology"), Spacer(1, 0.2*cm)]
story.append(Paragraph(
    "STEMI (ST-Elevation Myocardial Infarction) is a full-thickness (transmural) MI caused by "
    "complete and sustained occlusion of a coronary artery, almost always due to atherosclerotic "
    "plaque rupture with superimposed thrombus formation.", Body))
story.append(Paragraph("<b>Pathological sequence:</b>", Bold9))
for b in [
    "Plaque vulnerability → rupture/erosion",
    "Platelet aggregation → thrombus formation → complete occlusion",
    "Myocardial ischemia starts within minutes",
    "Irreversible necrosis begins at ~20 min (subendocardium first) — 'wavefront phenomenon'",
    "Near-complete transmural necrosis after ~6 hours without reperfusion",
]:
    story.append(bullet(b))
story.append(Spacer(1, 0.4*cm))

# ── 2. CLINICAL PRESENTATION ─────────────────────────────────────────────────
story += [h1_block("2. Clinical Presentation"), Spacer(1, 0.2*cm)]
rows = [
    ["Feature", "Classic", "Atypical (watch for!)"],
    ["Chest pain", "Crushing, pressure, radiation to left arm/jaw", "Absent — especially in diabetics, elderly, women"],
    ["Associated", "Diaphoresis, nausea, vomiting, dyspnea", "Epigastric pain, fatigue, syncope"],
    ["Duration", ">20 min, not relieved by nitrates", "Variable"],
]
story.append(section_table(rows, [3*cm, 7.5*cm, 6*cm]))
story.append(Spacer(1, 0.3*cm))
story.append(warning_box("High-risk for atypical presentation: Diabetics · Elderly · Women · Post-transplant patients"))
story.append(Spacer(1, 0.4*cm))

# ── 3. ECG DIAGNOSIS ─────────────────────────────────────────────────────────
story += [h1_block("3. ECG Diagnosis"), Spacer(1, 0.2*cm)]
story.append(Paragraph("<b>STEMI Diagnostic Criteria:</b>", H2))
rows = [
    ["Lead Group", "Elevation Threshold", "Territory"],
    ["2 contiguous limb leads (II,III,aVF or I,aVL)", "≥1 mm", "Inferior or Lateral"],
    ["2 contiguous precordial leads V1-V4", "≥2 mm men / ≥1.5 mm women", "Anterior"],
    ["V4R (right-sided lead)", "≥0.5 mm", "Right Ventricle"],
    ["V7-V9 (posterior leads)", "≥0.5 mm", "Posterior"],
]
story.append(section_table(rows, [6.5*cm, 5*cm, 5*cm]))
story.append(Spacer(1, 0.3*cm))

story.append(Paragraph("<b>ECG Evolution:</b>", H2))
evo = Table([[
    Paragraph("1\nHyperacute\nT waves", Small),
    Paragraph("→", Small),
    Paragraph("2\nST\nElevation", Small),
    Paragraph("→", Small),
    Paragraph("3\nPathological\nQ waves", Small),
    Paragraph("→", Small),
    Paragraph("4\nT wave\nInversion", Small),
    Paragraph("→", Small),
    Paragraph("5\nST normalises\nQ persists", Small),
]], colWidths=[2.5*cm, 0.6*cm, 2.5*cm, 0.6*cm, 2.5*cm, 0.6*cm, 2.5*cm, 0.6*cm, 2.5*cm])
evo.setStyle(TableStyle([
    ("BACKGROUND",    (0,0), (0,0),  colors.HexColor("#FDEDEC")),
    ("BACKGROUND",    (2,0), (2,0),  colors.HexColor("#FDEBD0")),
    ("BACKGROUND",    (4,0), (4,0),  colors.HexColor("#D5F5E3")),
    ("BACKGROUND",    (6,0), (6,0),  colors.HexColor("#D6EAF8")),
    ("BACKGROUND",    (8,0), (8,0),  LGREY),
    ("ALIGN",         (0,0), (-1,-1), "CENTER"),
    ("VALIGN",        (0,0), (-1,-1), "MIDDLE"),
    ("FONTSIZE",      (0,0), (-1,-1), 8),
    ("TOPPADDING",    (0,0), (-1,-1), 6),
    ("BOTTOMPADDING", (0,0), (-1,-1), 6),
    ("BOX",           (0,0), (-1,-1), 0.5, MGREY),
]))
story += [evo, Spacer(1, 0.3*cm)]

story.append(Paragraph("<b>STEMI Equivalents (Critical for EM!):</b>", H2))
rows = [
    ["Pattern", "ECG Finding", "Vessel / Notes"],
    ["De Winter", "Upsloping STD + peaked T waves V1-V6", "LAD occlusion — NO classic STE"],
    ["Posterior MI", "STD V1-V3 + tall R waves", "Do posterior leads V7-V9"],
    ["Wellens Syndrome", "Biphasic or deeply inverted T waves V2-V3", "Critical LAD stenosis — pre-infarction!"],
    ["New LBBB", "New or presumed new left bundle branch block", "Treat as STEMI"],
    ["Sgarbossa criteria", "Concordant STE ≥1 mm; STE ≥5 mm discordant", "Diagnose MI in LBBB"],
]
story.append(section_table(rows, [3.5*cm, 6*cm, 7*cm], header_bg=DARKRED))
story.append(Spacer(1, 0.3*cm))

story.append(Paragraph("<b>Territory Localisation:</b>", H2))
rows = [
    ["Territory", "Leads", "Artery"],
    ["Anterior",  "V1-V4",            "LAD"],
    ["Lateral",   "I, aVL, V5-V6",    "LCx"],
    ["Inferior",  "II, III, aVF",      "RCA (80%), LCx (20%)"],
    ["Posterior", "V7-V9 / STD V1-V3","RCA or LCx"],
    ["Right Ventricle", "V4R",         "RCA proximal"],
]
story.append(section_table(rows, [4*cm, 5*cm, 7.5*cm]))
story.append(Spacer(1, 0.4*cm))

# ── 4. ED DIAGNOSIS ──────────────────────────────────────────────────────────
story += [h1_block("4. Diagnosis in the ED"), Spacer(1, 0.2*cm)]
story.append(info_box(
    "⏱  KEY: 12-lead ECG must be acquired and interpreted within <b>10 minutes</b> of arrival (Class I — 2025 ACC/AHA).",
    bg=LGREEN, tc=GREEN
))
story.append(Spacer(1, 0.2*cm))
for b in [
    "<b>ECG:</b> 12-lead within 10 min; serial ECGs if initial non-diagnostic",
    "<b>hs-Troponin:</b> Measure ASAP — repeat at <b>1-2 hours</b> (rapid protocol) or 3-6 hours (standard)",
    "<b>Labs:</b> CBC, BMP, coagulation, BNP, lipid panel",
    "<b>CXR:</b> Portable — assess for pulmonary oedema, widened mediastinum",
    "<b>Bedside Echo:</b> If diagnosis uncertain — assess wall motion abnormalities, EF, pericardial effusion",
]:
    story.append(bullet(b))
story.append(Spacer(1, 0.4*cm))

# ── 5. REPERFUSION ──────────────────────────────────────────────────────────
story += [h1_block("5. Reperfusion Strategy — The Core of STEMI Management", bg=DARKRED), Spacer(1, 0.2*cm)]
story.append(Paragraph(
    "Timely reperfusion is the most effective method to restore myocardial oxygen supply. "
    "Every 30-minute delay in reperfusion increases mortality. Timely reperfusion has reduced "
    "in-hospital STEMI mortality from ~20% to ~5% over three decades.", Body))
story.append(Spacer(1, 0.2*cm))

story.append(Paragraph("<b>Time Targets (2025 ACC/AHA — Class I):</b>", H2))
rows = [
    ["Scenario", "Target", "Note"],
    ["PCI-capable hospital", "FMC → Balloon ≤ 90 min", "First medical contact to device"],
    ["Transfer from non-PCI hospital", "FMC → Balloon ≤ 120 min", "Accounts for transfer time"],
    ["Fibrinolysis (if PCI unavailable)", "FMC → Needle ≤ 30 min", "If PCI can't meet 120 min target"],
    ["Fibrinolytic bolus from diagnosis", "STEMI Dx → Bolus ≤ 10 min", "Prehospital lysis if feasible"],
]
story.append(section_table(rows, [5*cm, 5*cm, 6.5*cm], header_bg=DARKRED))
story.append(Spacer(1, 0.2*cm))
story.append(info_box(
    'ℹ "First Medical Contact to Device Time" replaces the old "door to balloon" / "door to needle" terminology.',
    bg=LBLUE, tc=BLUE
))
story.append(Spacer(1, 0.3*cm))

story.append(Paragraph("<b>Primary PCI vs Fibrinolysis:</b>", H2))
story.append(Paragraph(
    "In a large meta-analysis of 23 RCTs, pPCI was superior to thrombolytics at reducing "
    "death, reinfarction, and stroke. pPCI is always preferred when achievable within time targets.", Body))

story.append(Paragraph("<b>Absolute Contraindications to Fibrinolysis:</b>", H3))
for b in [
    "Prior intracranial haemorrhage (any time)",
    "Ischaemic stroke within 3 months",
    "Structural cerebrovascular lesion or intracranial neoplasm",
    "Active internal bleeding (not menses)",
    "Suspected aortic dissection",
    "Significant closed-head or facial trauma within 3 months",
]:
    story.append(bullet(b))

story.append(Paragraph("<b>Post-Fibrinolysis Strategy:</b>", H3))
for b in [
    "Successful lysis (≥50% ST resolution at 60-90 min) → Angiography within 3-24 hours (pharmacoinvasive strategy)",
    "Failed reperfusion → Rescue PCI IMMEDIATELY",
]:
    story.append(bullet(b))
story.append(Spacer(1, 0.4*cm))

# ── 6. PHARMACOTHERAPY ──────────────────────────────────────────────────────
story += [h1_block("6. Pharmacotherapy"), Spacer(1, 0.2*cm)]

story.append(Paragraph("<b>Antiplatelet Therapy (DAPT — Give Immediately):</b>", H2))
rows = [
    ["Drug", "Loading Dose", "Maintenance", "Notes"],
    ["Aspirin", "162-325 mg", "75-100 mg daily", "Give immediately to all"],
    ["Ticagrelor", "180 mg PO", "90 mg BD", "Preferred with pPCI (2025 Class I)"],
    ["Prasugrel", "60 mg PO", "10 mg daily", "Preferred with pPCI; AVOID if prior stroke/TIA, age >75, wt <60 kg"],
    ["Clopidogrel", "600 mg PO", "75 mg daily", "If ticagrelor/prasugrel unavailable; no load >75 yrs + fibrinolysis"],
]
story.append(section_table(rows, [2.8*cm, 2.8*cm, 3.5*cm, 7.4*cm], header_bg=GREEN))
story.append(Spacer(1, 0.2*cm))

story.append(info_box(
    "⭐ 2025 NEW (Class I): Transition to ticagrelor monotherapy ≥1 month post-PCI reduces bleeding risk. "
    "DAPT ≥12 months for low bleeding risk; shorter (1-3 months) for high bleeding risk.", bg=LGREEN, tc=GREEN))
story.append(Spacer(1, 0.3*cm))

story.append(Paragraph("<b>Anticoagulation:</b>", H2))
rows = [
    ["Drug", "Setting", "Dose"],
    ["UFH (Unfractionated Heparin)", "Primary PCI", "70-100 U/kg IV bolus (without GPI); 50-70 U/kg with GPI"],
    ["Bivalirudin", "Primary PCI", "Alternative to UFH; lower bleeding risk"],
    ["Enoxaparin", "Fibrinolysis/Medical", "30 mg IV + 1 mg/kg SC Q12H"],
    ["Fondaparinux", "Medical management", "2.5 mg SC daily — AVOID as sole agent for PCI"],
]
story.append(section_table(rows, [4*cm, 3.5*cm, 9*cm], header_bg=GREEN))
story.append(Spacer(1, 0.3*cm))

story.append(Paragraph("<b>Other Essential Drugs:</b>", H2))
rows = [
    ["Drug", "Indication", "Key Notes / Contraindications"],
    ["Beta-blockers (oral)", "All STEMI — within 24h", "Reduce VT/VF; AVOID in cardiogenic shock, acute HF, PR >240ms, 2°/3° block, active asthma"],
    ["ACE inhibitor / ARB", "All STEMI, esp. EF <40%", "Start within 24h; reduces MACE"],
    ["High-intensity statin", "All STEMI (Class I — 2025)", "Start immediately; goal LDL <70 mg/dL (or <40 if recurrent event)"],
    ["Nitrates", "Chest pain relief", "AVOID in RV infarction, hypotension (SBP <90), recent PDE5 inhibitor use"],
    ["Morphine", "Refractory pain only", "Use cautiously — may delay P2Y12 absorption"],
    ["Oxygen", "SpO2 <90% only", "Do NOT give routinely if SpO2 ≥90% — may cause harm"],
]
story.append(section_table(rows, [3.5*cm, 4*cm, 9*cm], header_bg=GREEN))
story.append(Spacer(1, 0.4*cm))

# ── 7. MULTIVESSEL DISEASE ───────────────────────────────────────────────────
story += [h1_block("7. Multivessel Disease in STEMI (2025 Major Update!)", bg=ORANGE), Spacer(1, 0.2*cm)]
story.append(Paragraph(
    "Approximately 50% of STEMI patients have multivessel disease (MVD). Management of noninfarct "
    "arteries is now well-defined by the 2025 guidelines.", Body))
rows = [
    ["Scenario", "Recommendation", "Class"],
    ["Haemodynamically STABLE STEMI + MVD",
     "Complete revascularisation recommended — at index PCI or within 45 days",
     "Class I"],
    ["Stable STEMI + low-complexity MVD",
     "Multivessel PCI at time of primary PCI may be preferred over staged approach",
     "Class 2b"],
    ["Cardiogenic SHOCK + MVD",
     "Routine PCI of noninfarct artery at time of primary PCI SHOULD NOT be performed — higher risk of death/renal failure",
     "Class III (HARM)"],
]
story.append(section_table(rows, [5.5*cm, 8.5*cm, 2.5*cm], header_bg=ORANGE))
story.append(Spacer(1, 0.4*cm))

# ── 8. COMPLICATIONS ────────────────────────────────────────────────────────
story += [h1_block("8. Complications of STEMI"), Spacer(1, 0.2*cm)]

story.append(Paragraph("<b>Early Complications (0-72 hours):</b>", H2))
rows = [
    ["Complication", "Key Features", "Management"],
    ["Ventricular Fibrillation (VF)", "Leading cause of early death", "Defibrillation, ACLS"],
    ["Complete Heart Block (inferior MI)", "Bradycardia, hypotension, wide QRS escape", "Atropine, temporary pacing"],
    ["RV Infarction", "Hypotension + JVD + clear lungs — 30-50% of inferior STEMIs", "IV fluids, avoid nitrates/diuretics, early pPCI"],
    ["Cardiogenic Shock", "SBP <90, cold/clammy, oliguria, low CO", "Primary PCI, vasopressors (noradrenaline), MCS"],
]
story.append(section_table(rows, [4.5*cm, 6*cm, 6*cm]))
story.append(Spacer(1, 0.2*cm))

story.append(Paragraph("<b>Mechanical Complications (Days 3-7 — free wall weakest):</b>", H2))
rows = [
    ["Complication", "Clinical Features", "Management"],
    ["Free Wall Rupture", "Sudden cardiac death; Beck's triad (tamponade)", "Emergency surgery / pericardiocentesis"],
    ["VSD (Ventricular Septal Defect)", "New harsh holosystolic murmur; step-up O2 sat RA→RV", "Emergency surgical repair; MCS bridge"],
    ["Papillary Muscle Rupture / Acute MR", "Acute pulmonary oedema; soft or no murmur", "Emergency MV surgery; IABP bridge"],
]
story.append(section_table(rows, [4.5*cm, 5.5*cm, 6.5*cm]))
story.append(Spacer(1, 0.2*cm))

story.append(Paragraph("<b>Subacute / Late Complications:</b>", H2))
rows = [
    ["Complication", "Timing", "Features & Treatment"],
    ["Dressler Syndrome (Post-MI Pericarditis)", "Weeks after MI", "Fever + pericardial rub + pleurisy; treat with aspirin/NSAIDs/colchicine"],
    ["LV Thrombus", "Days to weeks", "Echo diagnosis; anticoagulate with warfarin or NOAC x 3 months"],
    ["LV Aneurysm", "Weeks to months", "Persistent ST elevation; paradoxical wall motion; anticoagulate if thrombus"],
]
story.append(section_table(rows, [5*cm, 2.5*cm, 9*cm]))
story.append(Spacer(1, 0.4*cm))

# ── 9. KILLIP CLASSIFICATION ────────────────────────────────────────────────
story += [h1_block("9. Killip Classification"), Spacer(1, 0.2*cm)]
rows = [
    ["Class", "Signs", "In-Hospital Mortality"],
    ["I",   "No heart failure signs",          "~5%"],
    ["II",  "S3 gallop, basal rales <50% lung fields", "~10%"],
    ["III", "Pulmonary oedema (rales >50%)",    "~20-40%"],
    ["IV",  "Cardiogenic shock",                "~80%"],
]
story.append(section_table(rows, [2*cm, 9.5*cm, 5*cm]))
story.append(Spacer(1, 0.4*cm))

# ── 10. 2025 GUIDELINE KEY CHANGES ──────────────────────────────────────────
story += [h1_block("10. 2025 ACC/AHA ACS Guideline — Key Changes", bg=DARKRED), Spacer(1, 0.2*cm)]
story.append(Paragraph(
    "Published February 27, 2025 in Circulation (PMID: 40014670) and JACC. This landmark unified "
    "guideline replaces the 2013 STEMI, 2014 NSTEMI, 2015 PCI, and 2016 DAPT guidelines.", Body))
story.append(Spacer(1, 0.2*cm))
changes = [
    ("1. DAPT Transition (NEW — Class I)",
     "Ticagrelor monotherapy ≥1 month post-PCI is now Class I to reduce bleeding. DAPT ≥12 months for low bleeding risk."),
    ("2. Complete Revascularisation in MVD-STEMI (Class I)",
     "For haemodynamically stable STEMI + MVD: complete revascularisation at index PCI or within 45 days."),
    ("3. Cardiogenic Shock + MVD (Class III Harm)",
     "Do NOT routinely PCI the noninfarct artery at the time of primary PCI — increases death/renal failure."),
    ("4. Lipid Targets Updated",
     "High-intensity statin for all ACS (Class I). For recurrent events within 2 years on max statin: LDL target <40 mg/dL."),
    ("5. Aspirin Dosing",
     "Low-dose aspirin (≤100 mg/day) preferred for long-term maintenance therapy."),
    ("6. ECG + Troponin Protocols",
     "ECG within 10 minutes (Class I). Rapid hs-troponin protocols: 0h/1-2h or 0h/3-6h."),
]
for title, body in changes:
    story.append(Paragraph(f"<b>{title}</b>", H3))
    story.append(Paragraph(body, Body))
story.append(Spacer(1, 0.4*cm))

# ── 11. QUICK MEMORY AIDS ────────────────────────────────────────────────────
story += [h1_block("11. Quick Memory Aids for Exams"), Spacer(1, 0.2*cm)]

story.append(Paragraph("<b>Time Targets (Memorise These!):</b>", H2))
times = Table([
    [Paragraph("ECG", Bold9), Paragraph("10 min", Bold9)],
    [Paragraph("pPCI (PCI hospital)", Body), Paragraph("FMC → Balloon ≤ 90 min", Body)],
    [Paragraph("pPCI (transfer)", Body), Paragraph("FMC → Balloon ≤ 120 min", Body)],
    [Paragraph("Fibrinolysis", Body), Paragraph("FMC → Needle ≤ 30 min", Body)],
    [Paragraph("Lytic bolus from Dx", Body), Paragraph("STEMI Dx → Bolus ≤ 10 min", Body)],
], colWidths=[8*cm, 8.5*cm])
times.setStyle(TableStyle([
    ("BACKGROUND",    (0,0), (-1,0),  RED),
    ("TEXTCOLOR",     (0,0), (-1,0),  WHITE),
    ("BACKGROUND",    (0,1), (-1,1),  colors.HexColor("#FDEDEC")),
    ("BACKGROUND",    (0,2), (-1,2),  colors.HexColor("#FDEBD0")),
    ("BACKGROUND",    (0,3), (-1,3),  colors.HexColor("#FDFEFE")),
    ("BACKGROUND",    (0,4), (-1,4),  LGREY),
    ("GRID",          (0,0), (-1,-1), 0.5, MGREY),
    ("TOPPADDING",    (0,0), (-1,-1), 5),
    ("BOTTOMPADDING", (0,0), (-1,-1), 5),
    ("LEFTPADDING",   (0,0), (-1,-1), 8),
    ("FONTSIZE",      (0,0), (-1,-1), 9),
]))
story += [times, Spacer(1, 0.3*cm)]

story.append(Paragraph("<b>MONA — Updated for 2025:</b>", H2))
mona_data = [
    ["M", "Morphine", "Use CAUTIOUSLY — not routinely (delays P2Y12 absorption)"],
    ["O", "Oxygen", "Only if SpO2 <90% — AVOID routine O2 if ≥90%"],
    ["N", "Nitrates", "AVOID in RV infarction, hypotension, PDE5i use"],
    ["A", "Aspirin", "Give IMMEDIATELY — Class I, 162-325 mg load"],
]
mona = Table(
    [[Paragraph(f"<b>{r[0]}</b>", S("MC", fontSize=18, textColor=WHITE, fontName="Helvetica-Bold", alignment=TA_CENTER)),
      Paragraph(f"<b>{r[1]}</b>", S("MD", fontSize=10, textColor=DARKRED, fontName="Helvetica-Bold")),
      Paragraph(r[2], Body)] for r in mona_data],
    colWidths=[1.2*cm, 3*cm, 12.3*cm]
)
mona.setStyle(TableStyle([
    ("BACKGROUND",    (0,0), (0,-1), DARKRED),
    ("BACKGROUND",    (1,0), (-1,-1), LGREY),
    ("GRID",          (0,0), (-1,-1), 0.5, MGREY),
    ("VALIGN",        (0,0), (-1,-1), "MIDDLE"),
    ("TOPPADDING",    (0,0), (-1,-1), 6),
    ("BOTTOMPADDING", (0,0), (-1,-1), 6),
    ("LEFTPADDING",   (0,0), (-1,-1), 6),
]))
story += [mona, Spacer(1, 0.4*cm)]

story.append(Paragraph("<b>RV Infarction — Triad to Remember:</b>", H2))
story.append(info_box(
    "Hypotension  +  Elevated JVP  +  Clear Lungs (no pulmonary oedema)\n"
    "→ Occurs in 30-50% of inferior STEMIs  |  Check V4R lead  |  Give IV FLUIDS — AVOID nitrates/diuretics",
    bg=colors.HexColor("#FEF9E7"), tc=ORANGE
))
story.append(Spacer(1, 0.4*cm))

# ── REFERENCES ───────────────────────────────────────────────────────────────
story += [HRFlowable(width=W, color=MGREY), Spacer(1, 0.2*cm)]
story.append(Paragraph("<b>References</b>", H2))
refs = [
    "Tintinalli JE et al. Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 9th Ed. McGraw-Hill.",
    "Fuster V et al. Fuster and Hurst's The Heart, 15th Edition. McGraw-Hill.",
    "Braunwald E et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 12th Ed. Elsevier.",
    "Rao SV et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation. 2025. PMID: 40014670",
    "Faro DC et al. Complete PCI Revascularization in ACS With MVD: Systematic Review. JACC Cardiovasc Interv. 2023. PMID: 37821180",
]
for r in refs:
    story.append(bullet(r))

story.append(Spacer(1, 0.3*cm))
story.append(Paragraph(
    "Generated by Orris AI · July 2026 · For educational use only — always verify clinical decisions against current guidelines.",
    Small
))

# ── BUILD ─────────────────────────────────────────────────────────────────────
doc.build(story)
print(f"PDF saved: {OUTPUT}")

Running Command

cd /home/daytona/workspace/stemi-guide && python3 generate_stemi_pdf.py

Running Command

ls -lh /home/daytona/workspace/stemi-guide/STEMI_EM_Study_Guide.pdf

Your STEMI study guide PDF is ready! Here's the download link:

STEMI EM Study Guide

PDF Document · PDF

The PDF includes all 11 sections:

Definition & Pathophysiology
Clinical Presentation (classic vs atypical)
ECG Diagnosis - criteria, evolution, STEMI equivalents, territory localisation
ED Diagnosis workflow
Reperfusion strategy with time targets
Full pharmacotherapy tables (antiplatelets, anticoagulation, other drugs)
Multivessel disease - 2025 guideline updates
Complications (early, mechanical, subacute)
Killip Classification
2025 ACC/AHA key guideline changes
Quick memory aids (MONA updated, time targets, RV infarction triad)

All colour-coded with warning boxes and tables for easy revision. Good luck with your exams! 💪

Ur great

Thank you! 😊 That means a lot.

You've got a solid topic under your belt now. Whenever you're ready, just fire away with the next topic — whether it's trauma, toxicology, sepsis, airway management, or anything else on your exam list. I'm here to help you ace it! 🏥✅

Hey hii

Hey! Welcome back! 👋

Ready to tackle another topic, or is there something specific on your mind? 😊

Hypertensive emergency any recent updates and treatment in ed

Great topic for EM finals! Hypertensive emergencies are high-yield. Let me pull the latest from the medical library and recent guidelines.

Searching sources...

Reading File

Finding Sources

Searching PubMed

"hypertensive emergency" AND management

Searching the Web

hypertensive emergency 2024 2025 guidelines treatment ED updates

Excellent - rich results. Now let me pull the actual textbook content and extract the 2025 AHA guideline specifics:

Reading File

Reading Web Page

https://www.ahajournals.org/doi/10.1161/CIR.0000000000001356

Let me get the drug-specific details from Rosen's textbook and the ACEP 2025 policy update:

Reading File

Reading Web Page

https://home.hippoed.com/blog/asymptomatic-hypertension-ed-m…

I now have everything needed. Here is a comprehensive, exam-ready answer:

Hypertensive Emergency - Complete EM Guide + Latest Updates

1. Definitions (Updated 2025 Terminology!)

Term	Definition	Key Point
Hypertensive Emergency	Severe BP elevation (SBP ≥180 or DBP ≥120 mmHg) WITH acute target organ damage (TOD)	Requires IV therapy + admission
Severe Hypertension without TOD	Severe BP elevation WITHOUT acute TOD	⚠️ "Hypertensive urgency" is now retired (2025 AHA/ACC)
Asymptomatic Hypertension	Elevated BP without symptoms or TOD	ACEP 2025: Consider starting oral therapy at discharge

Exam tip: The term "hypertensive urgency" has been officially retired in the 2025 AHA/ACC Hypertension Guidelines and replaced with "severe hypertension without acute target-organ damage." This is a major terminology shift - expect it in MCQs!

2. Pathophysiology

Abrupt rise in BP overwhelms vascular autoregulation
Endothelial injury → fibrinoid necrosis of arterioles → ischemia
Brain: failure of cerebral autoregulation → vasogenic oedema (PRES/hypertensive encephalopathy)
Kidney: afferent arteriole injury → activation of RAAS → further BP rise (vicious cycle)
Heart: increased afterload → LV strain → acute HF/ACS

Most cases occur in patients with chronic hypertension - the one important exception is pregnancy (eclampsia), where abrupt BP rises in previously normotensive women can be catastrophic. - Rosen's Emergency Medicine

3. Target Organ Systems Involved

Organ System	Conditions	Approximate Incidence
Brain	Hypertensive encephalopathy, ischaemic stroke, intracranial haemorrhage	37-45%
Heart	Acute HF/pulmonary oedema, ACS	27-49%
Kidney	Acute kidney injury	8-15%
Vascular	Aortic dissection	1-2%
Other	Eclampsia, hypertensive retinopathy	2-3%

Critical point: Headache, dizziness, and epistaxis alone do NOT constitute a hypertensive emergency and do NOT mandate acute BP reduction. - Rosen's Emergency Medicine

4. ED Assessment

Step 1 - Confirm true emergency:

History: onset, symptoms (chest pain, SOB, headache, vision changes, focal neuro deficits, oliguria)
Physical exam: fundoscopy (papilloedema, haemorrhages), neuro exam, JVP, lung auscultation
Bilateral arm BP measurements

Step 2 - Workup:

ECG (LVH, ischaemia, arrhythmia)
CXR (pulmonary oedema, widened mediastinum)
Urinalysis + urine microscopy (haematuria, casts)
Serum creatinine, BUN, electrolytes
Troponin if chest pain
CBC, peripheral smear (MAHA - microangiopathic haemolytic anaemia)
CT head (if altered mentation, focal deficits)
CT chest/angio (if aortic dissection suspected)
Urine pregnancy test (all women of reproductive age)

5. BP Reduction Targets (Critical for Exams!)

Phase	Target	Timeframe
First hour	Reduce MAP by no more than 25%	Over 1 hour
Next 2-6 hours	Target BP ~160/100 mmHg	Gradual
Next 24-48 hours	Slow further reduction toward normal	Avoid overcorrection

Why not lower faster? Overly rapid BP reduction can precipitate ischaemia in organs adapted to high pressure (especially brain, kidneys). The autoregulation curve has shifted rightward in chronic hypertensives.

Exception - Conditions requiring FASTER/deeper reduction:

Condition	Target	Agent
Aortic dissection	SBP <120 mmHg in 20 min	Esmolol + nitroprusside/nicardipine
Ischaemic stroke (eligible for thrombolysis)	<185/110 before tPA	Labetalol or nicardipine
Ischaemic stroke (NOT for thrombolysis)	Only treat if BP >220/120	Labetalol
Hypertensive encephalopathy/PRES	25% MAP reduction over 1h	Nicardipine, labetalol
Eclampsia/pre-eclampsia	<160/110	Hydralazine, labetalol, nifedipine
Acute pulmonary oedema	Aggressive reduction	GTN/nitroglycerin, clevidipine

6. IV Drugs for Hypertensive Emergency

First-Line Agents

Drug	Dose	Onset	Duration	Best For	Avoid
Labetalol	20 mg IV bolus Q10min (max 300 mg); or 2 mg/min infusion	5-10 min	3-6 hrs	Most emergencies, aortic dissection, pregnancy	Asthma, acute HF, bradycardia
Nicardipine	5 mg/hr IV, titrate by 2.5 mg/hr Q5-15 min; max 15 mg/hr	5-15 min	30-40 min	Stroke, encephalopathy, eclampsia	Acute HF
Clevidipine	1-2 mg/hr, double Q90 sec; max 32 mg/hr	2-4 min	5-15 min	Peri-operative, acute HF	Soya/egg allergy, severe aortic stenosis
Sodium nitroprusside	0.3-0.5 mcg/kg/min, titrate	Seconds	1-2 min	Most emergencies (versatile)	Increased ICP, renal failure (prolonged use - cyanide toxicity), pregnancy
Nitroglycerin (GTN)	5-100 mcg/min IV infusion	2-5 min	3-5 min	Acute pulmonary oedema, ACS	Hypotension, RV infarction, PDE5i
Esmolol	250-500 mcg/kg bolus then 50-100 mcg/kg/min	1-2 min	10-20 min	Aortic dissection, tachycardia + HT	Asthma, acute HF
Hydralazine	10-20 mg IV Q20-30 min	10-30 min	2-4 hrs	Eclampsia/pre-eclampsia	Aortic dissection (reflex tachycardia), coronary disease
Fenoldopam	0.1-0.3 mcg/kg/min	5-15 min	30-60 min	Renal impairment (preserves renal blood flow)	Glaucoma
Phentolamine	5-15 mg IV Q5 min	1-2 min	10-30 min	Phaeochromocytoma, cocaine/sympathomimetic	CAD

Drug Selection by Clinical Scenario

Scenario	Drug of Choice	Avoid
Hypertensive encephalopathy / PRES	Nicardipine, labetalol	Nitroprusside (ICP)
Aortic dissection	Esmolol + vasodilator (nitroprusside/nicardipine)	Hydralazine, dihydralazine
Acute LV failure / pulmonary oedema	Nitroglycerin, clevidipine, loop diuretics	Labetalol, beta-blockers
ACS + hypertensive emergency	Nitroglycerin, beta-blocker	Hydralazine
Ischaemic stroke (tPA eligible)	Labetalol or nicardipine	Nitroprusside
Intracerebral haemorrhage	Nicardipine, labetalol	Nitroprusside
Eclampsia / pre-eclampsia	Hydralazine, labetalol, nifedipine	ACE inhibitors, nitroprusside
Phaeochromocytoma / cocaine	Phentolamine, benzodiazepines	Beta-blockers alone (unopposed alpha)
Acute kidney injury	Fenoldopam, nicardipine	NSAIDs
Sympathomimetic crisis (cocaine)	Benzodiazepines ± phentolamine	Beta-blockers alone

Classic trap: In cocaine-induced hypertensive emergency, never give beta-blockers alone - this causes unopposed alpha-adrenergic stimulation and worsens hypertension and coronary spasm.

7. Condition-Specific Management

Hypertensive Encephalopathy / PRES

Altered consciousness, severe headache, visual disturbance, seizures
MRI: T2/FLAIR hyperintensity - posterior white matter (occipital, parietal)
Treatment: IV nicardipine or labetalol; reduce MAP 25% over 1 hour
Usually reversible with BP control

Aortic Dissection

Most time-critical hypertensive emergency
Target SBP <120 mmHg and HR <60 within 20 minutes
Two-drug strategy: IV beta-blocker FIRST (esmolol/labetalol), then vasodilator (nitroprusside/nicardipine)
Never give vasodilator alone - causes reflex tachycardia and worsens shear force

Intracerebral Haemorrhage (ICH)

Target SBP <140 mmHg (safe and reduces haematoma expansion per ATACH-2/INTERACT2 trials)
Agent: IV nicardipine preferred for smooth BP control

Ischaemic Stroke

If tPA eligible: reduce BP to <185/110 mmHg before giving tPA; maintain <180/105 for 24h after
If NOT for thrombolysis: permissive hypertension (only treat if BP >220/120 mmHg)
"Let it be" - abrupt reduction worsens penumbral ischaemia

Eclampsia

Deliver the baby - definitive treatment
IV labetalol (20 mg bolus), hydralazine (5-10 mg IV), or oral nifedipine
IV magnesium sulphate for seizure prevention/treatment (NOT an antihypertensive)
Target BP <160/110 mmHg

8. Latest 2025 Updates - High Yield for Exams

2025 AHA/ACC Hypertension Guidelines (Published 2025)

Published in Circulation (full guideline):

"Hypertensive urgency" is RETIRED - now called "severe hypertension without acute target-organ damage"
IV nicardipine > labetalol for short-term BP target achievement (RCT evidence)
Clevidipine > nicardipine for speed of BP reduction
Drug selection should be based on pharmacology, mechanism, degree of TOD, and comorbidities
Asymptomatic inpatient hypertension: Exercise extreme caution - 40-50% of cases normalise spontaneously; IV as-needed antihypertensives associated with increased in-hospital mortality, AKI, and prolonged stay

ACEP July 2025 Clinical Policy - Asymptomatic Hypertension in ED

Replaces the 2013 ACEP guideline
New recommendation: Consider initiating oral antihypertensive therapy at ED discharge for select patients with asymptomatic elevated BP
Evidence: Initiating therapy leads to mean 11 mmHg reduction at follow-up without increased adverse events
Mandatory: Refer ALL patients for outpatient follow-up
Not a universal mandate - use clinical judgement

2024 ESC Hypertension Guidelines

New simplified BP classification
Lower treatment targets
Risk-driven management approach
Emphasis on better detection strategies

9. Special Situations

Renal failure + hypertensive emergency:

Fenoldopam preferred (renal protective - increases renal blood flow)
Avoid nitroprusside (cyanide/thiocyanate accumulation)

Sympathomimetic crisis (cocaine, amphetamines, phaeochromocytoma):

Benzodiazepines are first-line (decrease sympathetic drive)
Phentolamine for alpha blockade
Beta-blockers CONTRAINDICATED alone - unopposed alpha stimulation

Pregnancy:

Safe agents: Hydralazine, labetalol, nifedipine, methyldopa
AVOID: ACE inhibitors, ARBs, nitroprusside, direct renin inhibitors

10. Quick Memory Aid

"ABCDE" for hypertensive emergency workup:

A - Aorta (dissection? CT chest)
B - Brain (encephalopathy, stroke? CT head)
C - Cardiac (HF, ACS? ECG, troponin, CXR)
D - Drugs/toxins (cocaine, amphetamines, phaeo?)
E - Eclampsia (pregnancy test)

BP reduction rule: "25 in 1, 160 in 6, normal in 24-48"

Reduce MAP by ≤25% in first hour
Target ~160/100 by 6 hours
Normal over 24-48 hours (except dissection/eclampsia - faster!)

Sources: Rosen's Emergency Medicine 9th Ed. - Lippincott Pharmacology - 2025 AHA/ACC Hypertension Guidelines - ACEP 2025 Clinical Policy (Jul 2025) - Systematic Review, J Am Heart Assoc 2023, PMID: 37421281

Want me to generate this as a PDF like the STEMI guide, or shall we work through a clinical case on hypertensive emergency? 😊

Pathophysiology in flowchar manner

Let me generate a clean, detailed pathophysiology flowchart for you!

Generating Image

A detailed medical pathophysiology flowchart of hypertensive emergency for medical students. Clean white background, professional medical style with colored boxes and arrows. The flowchart should show: TOP: "TRIGGER: Abrupt Rise in Blood Pressure (SBP ≥180 / DBP ≥120 mmHg)" in a red box Arrow down to: "Overwhelms Vascular Autoregulation" in orange box Arrow down to: "Endothelial Injury & Dysfunction" in orange box Then splits into TWO parallel branches: LEFT BRANCH (Blue - Mechanical Stress): - "Increased Wall Shear Stress" - Arrow down: "Fibrinoid Necrosis of Arterioles" - Arrow down: "Platelet Aggregation + Fibrin Deposition" - Arrow down: "Microangiopathic Haemolytic Anaemia (MAHA)" RIGHT BRANCH (Purple - Neurohormonal): - "RAAS Activation + Sympathetic Surge" - Arrow down: "Angiotensin II + Aldosterone" - Arrow down: "Sodium & Water Retention + Vasoconstriction" - Arrow down: "Further BP Rise (Vicious Cycle)" with a curved arrow looping back up Both branches converge to a central box: "END-ORGAN ISCHAEMIA & DAMAGE" Then splits into FOUR organ-specific outcome boxes at bottom: 1. BRAIN (red): "Cerebral autoregulation fails → Vasogenic oedema → Hypertensive Encephalopathy / PRES / Stroke / ICH" 2. HEART (pink): "Increased afterload → LV strain → Acute HF / Pulmonary Oedema / ACS" 3. KIDNEY (yellow): "Afferent arteriole injury → GFR drop → AKI → Activates more RAAS (feeds vicious cycle)" 4. AORTA/VESSELS (green): "Shear force on aortic wall → Intimal tear → Aortic Dissection" Use color-coded boxes, bold labels, clear directional arrows, and include a small note at bottom: "Key concept: Organs adapt to chronic high BP — rapid reduction causes ischaemia. Reduce MAP max 25% in first hour."

Hypertensive Emergency Pathophysiology Flowchart

Here's the complete pathophysiology flowchart! Here's a quick walkthrough:

The two key mechanisms running in parallel:

Mechanical pathway - High pressure physically damages arteriolar walls → fibrinoid necrosis → MAHA (look for schistocytes on blood smear!)
Neurohormonal pathway - Endothelial injury activates RAAS → more angiotensin II → more vasoconstriction → BP rises further → the vicious cycle that makes hypertensive emergencies self-perpetuating

Why the 4 end-organs matter in your exam:

Brain - Autoregulation fails, cerebral oedema → encephalopathy/PRES
Heart - Sudden afterload increase → LV can't cope → acute HF or ACS
Kidney - Arteriole necrosis → AKI → activates even MORE RAAS (feeds the cycle)
Aorta - Shear stress tears the intima → dissection (most time-critical!)

The golden clinical concept at the bottom: Chronic hypertensives have a right-shifted autoregulation curve - their organs need higher pressures to perfuse. Drop BP too fast and you cause ischaemia. That's why the 25% MAP rule in 1 hour exists.

Want me to do similar flowcharts for treatment algorithm or any other topic? 😊

This is a shared conversation. Sign in to Orris to start your own chat.